Details of the Drug Formulations

General Information of Drug (ID: DM0659E)

• Drug Name: Cannabidiol Drug Info
• Synonyms: cannabidiol; 13956-29-1; (-)-Cannabidiol; (-)-trans-Cannabidiol; Epidiolex; UNII-19GBJ60SN5; (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; delta1(2)-trans-Cannabidiol; (-)-CBD; GWP42003-P; CBD; 19GBJ60SN5; QHMBSVQNZZTUGM-ZWKOTPCHSA-N

Indication

Disease Entry	ICD 11	Status	REF
Dravet syndrome	8A61.11	Approved	[1]
LennoxGastaut syndrome	8A62.1	Approved	[1]
Infantile spasm	8A62.0	Phase 3	[2]
Epilepsy	8A60-8A68	Phase 2	[2]

• Cross-matching ID:
  PubChem CID: 644019
  ChEBI ID: CHEBI:69478
  CAS Number: 13956-29-1
  TTD ID: D0O1UZ
  VARIDT ID: DR00249
  INTEDE ID: DR0265
  ACDINA ID: D00909

Full List of Drug Formulations Containing This Drug

Cannabidiol 1.938 g/100 ml spray

Company	Formulation ID	FDA Description
Creative Essences	F23665	Water; Anhydrous Citric Acid; Glycerin; Potassium Sorbate; Rebaudioside A; Peppermint Oil; Polyoxyl 40 Castor Oil

Cannabidiol 100 mg/ml solution

Company	Formulation ID	FDA Description
Greenwich Biosciences	F23664	Dehydrated Alcohol; Sesame Seed Oil; Strawberry Flavor; Sucralose

References

• [1] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)